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 Open microfluidic device was developed using the open-access 
microfluidic device with through-hole membrane for the regenerative 
medicine of Peripheral arterial disease (PAD). PAD is commonly defined 
as narrowing of blood vessels in the lower part of arteries or arterioles. 
Major risk factors of occurrence of PAD include smoking, hypertension, 
hypercholesterolemia, atherosclerosis, and complications of diabetes. To 
develop safe and effective procedures for vascularized tissue injection, we 
focused on open microfluidic device using through-hole membrane and 
open-access microfluidic device system. For the transplantable tissue 
 ii 
culture, simple fabrication method of through-hole membrane was 
developed for the media supply to the tissue. Due to the small scale of the 
fabricated pores, the construction of through-hole membranes on a large 
scale and with relatively large areas faces many difficulties. Novel 
fabrication methods for a large-area, freestanding micro/nano through-
hole membrane constructed from versatile membrane materials using 
through-hole membranes on a microfluidic chip (THMMC) for the 
reconstitution of 3D tissue. The through-hole site was easily customizable 
from the micro to the nanoscale, with a low or high aspect ratio giving rise 
to reliable membranes. Also, the rigidity and biocompatibility of the 
through-hole membrane are easily tunable by simple injection of versatile 
membrane materials to obtain a large area (up to 3600 mm2). And we 
describe a simple, versatile method of generating open-access 
microfluidic device (OAMD) with possible non-destructive tissue 
sampling for TEM imaging. Generally, the analysis of organ-on-a-chip 
usually applied by optical microscope, fluorescence microscope and 
confocal microscopy. Although optical imaging technologies are 
widespread and effective observational tools, they possess functional and 
resolution limitations. The myelination by Schwann cells is critically 
important in restoring neuromuscular motor function after injury or 
 iii 
peripheral neuropathy, and in the case of quantifying myelination, 
transmission electron microscope (TEM) analysis is a requisite. The 
proposed OAMD platform incorporated a novel biocompatible self-
detachable photopolymer (BSP) substrate to provide a viable closed 
microphysiological system culture environment while also allowing for 
controllable and nondestructive tissue sampling for TEM analysis. 
Furthermore, We herein thesis a novel transplantable tissue engineering 
technique that yields functional and vascularized tissue that can be 
successfully transplanted into the Balb C Nu nude mouse using THMMC 
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1-1. Open Microfluidic Platform 
 Microfluidics [1] as a field has rapidly developed over the last few 
decades as a means of replicating human in vivo [2] rheological conditions 
and conducting single cell scale analysis [3] for drug screening and drug 
delivery system development. [4] Human biomimetic microfluidic 
devices are often referred to as ‘organ on a chip’ [5, 6] systems, and span 
various organs and tissues, such as lungs, [7] guts, [8] skin, and kidneys. 
[9] These chips rely on through-hole membranes to emulate human in vivo 
rheological conditions for cell-to-cell and tissue-to-tissue separation 
layers. Additionally, microfluidic devices [10] have also been applied to 
single cell trapping techniques. [11] Although organ on a chip has high 
precision mimic system, it suffers from the disadvantages inherent in the 
collection for analysis and transplantation of cells in a closed system, as 
cells are not accessible for re-collection once they have been analyzed.[12] 
In this thesis proposed the engineering and validation of open microfluidic  
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Figure 1-1. The system of human body on a chip for high throughput of 
drug screening. The organ on a chip has developed as diverse advantages 
by PDMS closed system. However, the closed system has disadvantages 





platform for the advanced organ on a chip analysis and application of the 
tissue engineering. The organ on a chip was well designed system for the 
three-dimensional tissue culture system by PDMS closed system. 
However, by the closed system, it has the disadvantage of nondestructive 
tissue sampling and transplantation. For the open microfluidic device, the 
through-hole membrane which was commonly used as a part of the organ 
on a chip, and self-detachable film which was used for the nondestructive 
tissue sampling was needed.   
 
1-2. Novel Fabrication Process of Through-hole 
Membrane 
 An alternate method utilizing a micro/nano membrane made of 
biocompatible PDMS [13] for cell trapping allows for the collection of 
cells after they have already been analyzed - though, this method requires 
a membrane that is comparatively more difficult and less efficient to 
fabricate.[14] Conventionally, the through-hole membrane is fabricated 
by MEMS processes such as imprinting [15] or micromolding in 
capillaries (MIMIC). [16, 17, 18, 19] The imprinting process involves 
applying a liquid pre-polymer to a flat surface, and then pressing a positive 
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pillar patterned mold into the pre-polymer layer. Imprinting exhibits 
disadvantages concerning residues around the cast perforations due to the 
inherent nature of the viscosity and wetting characteristics of the 
membrane pre-polymer. Should the pressure applied to the positive pillar 
patterned mold prove insufficient, the imprinting process may leave an 
undesirable closed negative structure within the membrane rather than a 
complete hole. As such, the applied pressure on the pillar patterned mold 
must be tuned depending on the viscosity of the membrane pre-polymer. 
Due to the critical nature of accounting for applied pressure and 
membrane pre-polymer viscosities, the reliable fabrication of uniformly 
thick and reliably patterned large area membranes is quite difficult. Other 
conventional fabrication methods such as MIMIC, manual punching, spin 
coating, and MEMS-based etching also harbor unsuitable characteristics. 
For instance, MIMIC, which involves capillary driven injection, is not 
suited for large area membrane fabrication. Manual punching using a 
gauged needle or biopsy punch is both time consuming and limited in size 
due to the availability of the punch. Spin coating results in the formation 
of a defective meniscus at the perforation site, and may even result in an 
unwanted residual layer if the spin conditions are not precisely controlled. 
Conventional MEMS-based etching [20] requires expensive machinery 
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for fabrication, and also involves toxic gases in the fabrication process. In 
a novel fabrication procedure proposed by Cho et al., [21] micro and nano 
scale through-holes can be produced comparatively more conveniently 
and accurately through the use of a hierarchical mold under specially 
confined pressure conditions.  
 This thesis describes a novel fabrication method for a multiscale 
through-hole membrane on a microfluidic chip (THMMC). Membrane 
fabrication takes place in three steps beginning with plasma bonding of 
the top part of a PDMS microfluidic chip with a flat or nano-patterned 
substrate. Secondly, the membrane material (pre-polymer) is injected 
through a microfluidic channel then cured. Lastly, the mem- brane is 
separated from the microfluidic chip via cutting and mechanical force. 
This novel fabrication process does not apply any pressure to the top and 
bottom components, especially during curing of the pre-polymer. The 
diameter of the fabricated through-hole membrane created through this 
process ranges from a hundred micrometers to a hundred nanometers, 
depending on the positive patterned top and bottom components. The nano 
through-hole membrane is fabricated as a hierarchical structure. The 
microfluidic channel, as the top part component, supports the handle area 
for the micro- pillar plasma-bonded with the nanopillar patterned 
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substrate which was the section of the nano through-hole membrane area. 
The hierarchically structured nano through-hole mem- brane exhibits high 
durability and stability, with significant resistance to tearing when the 
through-hole site has a low aspect ratio (<1) and sub-micrometer thickness 
near the opening. This novel fabrication method gives a high yield and is 
viable for large area (3600 mm2) production using a 4 inch wafer-based 
microfluidic chip mold. The through-hole membrane was obtained from 
a freestanding [22] film and the shape can be tuned as pillar and conical 
[23, 24] types. The membrane rigidity can be altered by the pre-polymer 
injection method.  
 
1-3. Open-Access Microfluidic Device for TEM Analysis 
 Given the controversy surrounding the ethics of animal testing, recent 
trends have seen an increase of animal testing bans on ethical grounds. 
[25] To address the demands of in vivo testing results without the use of 
animal, organ on a chip technologies were developed to deliver in vivo 
like in vitro tissue culture platforms. Organ on a chip platforms are 
generally comprised of microstructured biocompatible devices, such as 
PDMS, plasma bonded to glass. To mimic in vivo structures, biomimetic 
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platforms have largely adopted three-dimensional cell culture techniques 
such as micropost compartmentalized microfluidic coculture devices. [26, 
27] These biomimetic platforms, like lung on a chip, liver on a chip, and 
lung on a chip, were designed to mimic specific human organ functions 
as closed microphysiological systems. [28, 29, 30, 31] However, 
microfluidic devices operate as closed systems, wherein coculture and 
microchannel chambers are confined between permanently bonded 
PDMS and glass. Generally, the analysis of organ on a chip usually 
applied by optical microscope and confocal microscopy. Although optical 
imaging technologies are widespread and effective observational tools, 
they possess functional and resolution limitations. [32] Observation of 
phenomena like the axonal myelination of motor neurons by Schwann 
cells require nanometer scale resolution that is infeasible using 
conventional optical imaging. [33, 34, 35] In the case of quantifying 
myelination, confirming histological responses to drug administration, 
and other subtle and difficult to image phenomena, transmission electron 
microscope (TEM) analysis is a requisite. As conventional closed 
microfluidic devices prevent the nondestructive retrieval of tissues for 
analysis, there is a need for an openly accessible alternative which permits 
for higher resolution imaging. An open microfluidic chip could also see 
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potential use in application like chemotactic in situ mRNA isolation, and 
open channel studies. [36, 37, 38, 39] 
 
1-4. Transplantation of 3D Tissue as Regenerative Medicine 
 Peripheral arterial disease (PAD) is commonly defined as narrowing of 
blood vessels in the lower part of arteries or arterioles. Major risk factors 
of occurrence of PAD include smoking, hypertension, 
hypercholesterolemia, atherosclerosis, and complications of diabetes [40]. 
According to a survey, PAD is prevalent and more than 5 million adults 
suffered from PAD in the United States [41]. In the PAD progression, 
patients might have limb pain with ischemic ulceration and gangrene. In 
the late stages of PAD, major limb amputation may be required [42]. 
Cellular implantation, a technique involving the injection of tissue into the 
PAD, was developed as an alternative therapeutic strategy for PAD failure. 
Several studies of PAD using various cell sources have successfully 
demonstrated improved function of the damaged vessel and subsequent 
regeneration of new vessels. However, significant problems are associated 
with cellular PAD due to the low nutritional supply in the tissue, and a 
proper anchoring matrix. Hence, the creation of an acceptable cell 
environment is a central issue in the need to improve the effectiveness of 
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regenerative medicine. To address the limitations of cellular PAD, a tissue 
engineering approach was developed to provide alternatives. The organ 
changes its shape from a sheet-like arrangement with primitive cells to 
mature three-dimensional structures through morphogenetic processes. 
[43, 44, 45] As regenerative medicine, a wide range of biomaterials have 
been used for the total or partial replacement of damaged organs and/or 
tissue structures. [46, 47, 48] As the functions of the living organ are 
realized by periodic changes in the lateral arrangement of tissue elements, 
multiform scaffold systems mimicking the native tissue are desired. The 
casting and electrospinning have been introduced to fabricate diverse 
scaffolds. [49, 50] However, these fabrication processes have limitations 
for organ like structure productions. Although recent progress in tissue 
engineering has focused on using 3D printer schemes, there are still 
limitations such as the shortage of appropriate printing materials and 











 There are many proposed mechanisms by which single cells can be 
trapped; among them is the through- hole membrane for the 
characterization of individual microorganisms. Due to the small scale of 
the fabricated pores, the construction of through-hole membranes on a 
large scale and with relatively large areas faces many difficulties. This 
thesis describes novel fabrication methods for a large-area, freestanding 
micro/nano through-hole membrane constructed from versatile membrane 
materials using through-hole membranes on a microfluidic chip 
(THMMC). This process can rapidly (<20 min) fabricate membranes with 
high fidelity multiscale hole size without residual layers. The through-
hole site was easily customizable from the micro to the nanoscale, with a 
low or high aspect ratio giving rise to reliable membranes. Also, the 
rigidity and biocompatibility of the through-hole membrane are easily 
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tunable by simple injection of versatile membrane materials to obtain a 
large area (up to 3600 mm2).  
 
2-2. Materials and Method 
2-2-1. Through-Hole Membrane by Microfluidic Chip 
(THMMC) 
 The experimental through-hole membrane was fabricated by applying 
pre-polymer membrane material through a PDMS microfluidic chip 
patterned with distribution channels into a mold. For microscale 
membrane production, the PDMS microfluidic prepolymer distribution 
chip is also patterned with positive micropillars and plasma bonded to a 
flat surface backer, like glass in Figure 2-1. With nanoscale membranes, 
the membrane molding chamber of the PDMS chip is bonded to a 
nanopatterned PEG-DA surface rather than a flat glass backer in Figure 
2-3. The bottom of the entire membrane is embedded with nanopatterning, 
with the actual transmembrane pores existing where the nanopatterned 
posts of the PEG-DA backer overlap with the PDMS microposts. Post 
injection, the assemblies are cured and then the membranes are 
mechanically extracted for use. The negative micropillar patterned master 
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was fabricated using a conventional lithography process with SU-8 
photoresist [55] (SU-8 100, MicroChem. the USA) for the positive 
micropillar patterned microfluidic chip. The mold was replicated from the 
negative patterned SU-8 master using PDMS (Sylgard 184, Dow Corning, 
USA). The comparatively large inlet/outlet ports were punched via 1mm 
medical grade skin biopsy punch (diameter 1 mm, Picu Punch) for 
membrane material injection channels. The PEG-DA surfaces were 
fabricated using the UV replica molding method in which PEG-DA UV 
curable solution was mixed with 97% (by mass) of polyethylene glycol 
diacrylate (PEG-DA, Mn 250, Sigma-Aldrich, viscosity 15 ~ 35 cP) pre-
polymer with 3% (by mass) of 1-hydroxy-cyclohexyl-phenyl-ketone 
(Irgarcure 184, BASF) as photo-initiator. The UV curable PEG-DA 
solution was applied to a Si wafer for fabrication of the flat substrate, and 
on a nano/micro patterned silicon master for the fabrication of the positive 
nano/micro patterned substrate. A flexible and clear polyester film was 
pretreated on both sides for enhanced adhesion to the UV curing resin 
(Thickness: 100 µm, skyrol V7200, SKC, Korea), was then placed on the 
UV resin and roll-pressed against the liquid ten times at a pressure of 2 ~ 
3 bars. The PEG-DA layer thickness was measured to be 30 ~ 40 µm after 
pressure rolling. [13] Next, the PEG-DA layer was cured under UV light 
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for 120 seconds (UV wavelength: 250–400 nm, dose: 100 mJ/cm2). After 
separating the PE backing panel from the wafer, a flat PEG-DA sheet was 
obtained on the PE Film. The PEG-DA replica mold was duplicated from 
a negatively patterned silicon master mold using the same protocol as the 
flat PEG-DA mold. 
 
2-2-2. Distribute Microfluidic Channel  
 A PDMS based microfluidic distribution chip was designed with a 
network of microfluidic channels to facilitate the efficient and bubble-less 
application of membrane pre-polymer across a 60 mm x 60 mm wide area 
during the material injection process in Figure 2-1. 
 
2-2-3. Micro / Nano Membrane  
 The membrane was fabricated in three simple steps in Figure 2-1b. The 
first step combines plasma bonding of the top part of a PDMS microfluidic 
chip with a flat or nanopatterned substrate. The microfluidic chip for a 
through-hole membrane was created using air plasma at the fixed 
condition of 45 sccm, 50 mTorr, 50 W, and 1 min (CUTE MPR, Femto 
Science, Korea), leaving behind a microfluidic channel with a flat surface 
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for the microscale membrane. For the nanoscale through-hole membrane, 
the PDMS microfluidic channel was created using air plasma bonding 
with a nanopillar patterned substrate at the same fixed condition, which 
was made by the PEG-DA nano patterned mold. The second step is 
injection and curing, in which the membrane material (pre-polymer) is 
injected through the microfluidic distribution channels then cured. The 
inner surfaces of the PDMS microfluidic chip were coated with a 
fluoropolymer to decrease inner surface energy, carried in a solution of 2 % 
(by mass) of Polytetrafluoroethylene (PTFE, Teflon, Dupont) in 98% (by 
mass) of solvent (Fluorinert FC-40, 3M). [56] The PDMS pre-polymer 
mixture with the curing agent was then injected into the microfluidic 
channel using a syringe pump at a flowrate of 0.1 ml/min. The PDMS 
membrane was then cured for 2 h at 70 °C. As the PDMS membrane was 
plasma bonded to a slab of PDMS for easy separation from the 
microfluidic chip, the membrane exhibits high flexibility and low 
mechanical modulus. There was a variety of UV curable materials injected 
into the microfluidic chip utilizing a syringe pump (0.1 ml / min) without 
any additional fluorinated coating processes about the intra surface of 
PDMS microfluidic chip. When curing the membrane materials, the chip 
was exposed to UV light for 180 s (UV wavelength = 250–400 nm, dose 
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= 100 mJ/cm2). The third, step is separating the membrane by mechanical 
failure, using a scalpel and a mechanical force. The PDMS microfluidic 
chip edge was severed using a scalpel and the micro/nanopillar substrate 
was separated using cohesive mechanical failure on the bottom surface 
after curing.  
 
 
2-3. Results and Discussion 
2-3-1. Microscale Through-hole Membrane 
Microfluidic pre-polymer distribution chips were fabricated through 
conventional means with single injection ports to the sides, each 
branching into four distribution channels for even pre-polymer application. 
Micro scale membranes were fabricated using a flat glass or flat PEG-DA 
coated PE film as backers in Figures 2-1. PDMS/Glass plasma bonding is 
a well-known combination for microfluidic research but PDMS/PEG-DA 
is relatively uncommon. PDMS/PEG-DA plasma bonding was processed 
under the same plasma treatment conditions as PDMS/Glass plasma 
bonding, but post thermal treatment was applied at 150  for 5 min in 
order to mitigate injection pressure induced material failure. Figure 2-3 
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shows a 3600 mm2 PDMS micro-through-hole array membrane with 80 
µm diameter holes and 200 µm spacing between holes. As shown in 
Figures 2-2a-i-iv, through-hole fabrication succeeded in generating high-
accuracy holes throughout the membrane, with an aspect ratio of 0.8, and 
no detectable meniscus formation at the edge of each hole site. As 
demonstrated, it is possible to generate high accuracy through hole arrays 
on a large area membrane. Membranes produced in this manner can be 
easily integrated to other PDMS based microfluidic chips via plasma 
bonding in a modular manner for a myriad of diagnostic designs. Thin 
PDMS membranes with microscale thickness also have many applications 
in flexible display and electronically sensitive surface technologies due to 
high flexibility and conformal contact adhesion characteristics. Figures 2-
2 show the versatility of producible through-hole shapes, sizes, and aspect 
ratios using modifiable casting components to vary output to the desired 
specification. The device cast in Figure 2-2c was fabricated using a 
smaller micropattern than that of Figure 1c, and was observed to have a 
higher aspect ratio of 2.5. Controlled over-exposure to UV in the SU-8 
photoresist master can be used to generate conical through-holes. With all 
other fabrication protocols held constant, the demonstration model conical 
membrane was shown to have top through-hole diameters of 25 µm and 
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bottom diameters of 9 µm. The membrane materials applied was 
polyurethane acrylate UV curable resin. The through-hole membrane was 
successfully fabricated for the low and high aspect ratio through-hole 
membrane or conical type as the diameter of the holes ranged from 80 µm 
to 9 µm. Following this research, the diverse rheology at the through-hole 
site which based on the solidified polymeric membrane was easily tunable 
















Figure 2-1. a) Components of microscale through-hole membrane 
fabrication using a microfluidic chip. The top part of the fabrication 
assembly is a PDMS based microfluidic membrane pre-polymer 
distribution chip for the controlled and even application of membrane pre-
polymer to the micro/nano scale pillar patterning mold below. The 
substrate used was a flat glass or PEG-DA coated polyethylene film. b) 
Schematic illustration for fabrication of the microscale through-hole 
membrane. Protocol consists of plasma bonding, polymer injection & 
curing and separation steps. The total membrane area was 60 mm by 60 







Figure 2-2. a) PDMS through-hole membrane (size: 6 x 6 cm2) and i~iv) 
FE-SEM image, respectively. This micromembrane has a low aspect ratio 
(AR: 0.8). The scale bar indicates a) 1 cm, a-i) 800 µm, a-ii) 200 µm, a-
iii) 60 µm, a-iv) 40 µm. b) Illustration images of high aspect ratio (AR: 
2.5) micromembrane. Cross-sectional image and magnitude image of high 
AR micromembrane. Hole diameter was 40 µm. The scale bar indicates 
50 µm and 30 µm. c) Illustrations of conical micromembrane and cross 
sectional image of conical type through-hole membrane. The upper hole 
diameter was 25 µm and lower hole diameter was 9 µm. The scale bar 






Figure 2-3. a) Variety of membranes made by the following materials; 
Hard-PUA, Soft-PUA, Elastic-PUA, PDMS and PEG-DA. The hole 
diameters of (80 µm) and space (200 µm) of f-i~v) were the same structure 








 While Figure 2-4 shows only the circular ‘dot’ patterned pores, other 
shapes like arrow, diamond, square brackets, semicircular arch, star, in 
any combination, can also be fabricated. The diversity of pore shapes can 
lead to a highly flexible platform with many applications, such as cell-cell 
and cell-tissue studies, synthesis, and more. 
 The micro-membrane is able to be fabricated using a variety of materials, 
though most of the devices used for cell culturing in this thesis are made 
of thermo-curable and highly biocompatible PDMS. In addition to 
thermally curable polymers like PDMS, there are also UV curable 
materials like PEG-DA (Polyethyleneglycol diacrylate) which were also 
used.  PEG-DA, which is both biocompatible and has a low (20 ~ 30 cP) 
viscosity while in the liquid prepolymer state, was used to cast the 
membrane depicted in Figure 1f. Other UV curable polymers were also 
selected for various mechanical and chemical properties and cast into 
through hole membranes for testing.  Such polymers used, and their 
corresponding are as follows: hard-PUA (polyurethane acrylate) (E : > 
320 MPa, 100 ~ 150 cP) [57], soft-PUA (E : ~ 19.8 MPa, 200 ~ 260 cP), 
[57] and elastic-PUA (E : ~ 2 MPa, 2500 ~ 2600 cP) [58] at similar level 
of PDMS (E : ~ 2 MPa, 3500 cP). As all membrane polymers were directly 
applied to the casting surface through PDMS based microfluidic channels, 
 22 
all pre-polymer material viscosities needed to be accounted for. PEG-DA, 
hard-PUA, and soft-PUA, having low viscosity values, were injected at a 
1 ml/min rate, while elastic-PUA and PDMS with their high viscosity 
values were injected at 0.2 ml/min. Accounting for the viscosities of 
membrane pre-polymers during microchannel injection allowed for the 
mitigation of unwanted residue formation during the casting process. It is 
interesting to note, however, that microscale casting can take place 















Figure 2-4. A detailed SEM image for the diverse design of micro 
membrane. All of the white scale bar indicates 500 µm except trigonal arrow 









2-3-2. Nanoscale Through-hole Membrane 
 In Figures 2-5 nanoscale through-hole membranes are fabricated through 
the use of a plasma bonded micropillar arrayed PDMS microfluidic 
channel with a nanopillar patterned PEG-DA mold.  The diameter and 
height of the nanopillar pattern were 400 nm and 740 nm (an aspect ratio 
of 1.6), respectively. This interconnection makes a nano through-hole site 
though a simplified process that does not require a hierarchical mold. 
Generally, nanoscale membranes of this type suffer from low fracture 
toughness, especially at thicknesses around or under 100 nm. To help 
mitigate the thickness induced mechanical frailty, hard-PUA (MINS 
311RM) was selected for its high Young’s Modulus (>320 MPa) as the 
membrane material. An 80µm thick hierarchical structure, designed for 
high fracture resistance, was also implemented to further strengthen the 
membrane. The microfluidic channel replica was designed as a support 
frame for the nanomembrane in the entire membrane area. The hexagonal 
area in Figure 2-6 represents the nano through-hole site, while the planar 
area represents a support area. As shown in the cross sections in Figures 
2-6-ii-iv, the fabricated nano-hole membrane has a thickness of 740 nm 
and a hole diameter of 400 nm. 
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Figure 2-5. a) Illustration of the hierarchical nanoscale through-hole 
membrane from a microfluidic chip bonded with a nanopatterned 
substrate. b) Schematic illustration of the fabrication of a nanoscale 
through-hole membrane. Protocol consisted of plasma bonding, polymer 
injection & curing and separation steps. The nano through-hole area was 
fabricated within the plasma bonded area comprising of the micropillar 










Figure 2-6. a-i) Eight honeycomb structured areas were nanomembrane 
areas. The other areas were closed areas for membrane support. a-ii, iii) 
Top view image of one nano through-hole membrane where the moire 
patterns were obtained at low magnitude scale and magnitude image of 
nano through-hole area. a-iv, v) Cross-sectional image of nano through-
hole membrane. The nanoscale through-hole membrane was obtained. 











 This thesis presents a simple approach to the fabrication of micro and 
nano scale through-hole membranes. Fabrication takes place in a three 
step process of plasma bonding, membrane material injection and curing, 
and then the extraction of the completed membrane. The process itself is 
highly scalable, modular, and compatible with a very diverse range of 
different polymers to achieve desired specifications.  Based on the intra 
structure rheology of microfluidic chip, the membrane pore diameter was 
decreased from hundreds of microns to hundreds of nanometers. Through-
hole structures can be fabricated in both cylindrical pillar type and conical 
types, with many options of customizing height, width, and aspect ratio to 
desired specifications. Using this process, fabricated membranes have a 
high degree of uniformity of thickness, no residues, and no meniscus 








Open-Access Microfluidic Device for TEM 
analysis of 3D Reconstituted Myelin Sheaths 
 
3-1. Introduction 
 Here, we describe a simple, versatile method of generating open-access 
microfluidic device (OAMD) with possible non-destructive tissue 
sampling for TEM imaging. Generally, the analysis of organ-on-a-chip 
usually applied by optical microscope, fluorescence microscope and 
confocal microscopy. Although optical imaging technologies are 
widespread and effective observational tools, they possess functional and 
resolution limitations. The myelination by Schwann cells is critically 
important in restoring neuromuscular motor function after injury or 
peripheral neuropathy, and in the case of quantifying myelination, 
transmission electron microscope (TEM) analysis is a requisite. As 
conventional closed microfluidic devices prevent the nondestructive 
retrieval of tissues for analysis, there is a need for an openly accessible 
alternative which permits for TEM imaging. The proposed OAMD 
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platform incorporated a novel biocompatible self-detachable 
photopolymer (BSP) substrate to provide a viable closed 
microphysiological system culture environment while also allowing for 
controllable and nondestructive tissue sampling for TEM analysis. BSP is 
also capable of high fidelity UV lithographic nanoimprinting which can 
be useful for topography mediated cell behavioral studies. With the added 
capability of nondestructive tissue sampling, the OAMD platform shows 
promise as a bridge between the precision and controllability of closed 
microphysiological culturing and the capability for high resolution 




Figure 3-1. a) The open-access microfluidic device (OAMD) was 
composed of biocompatible and self-detachable photopolymer (BSP) as a 
substrate material which was plasma-bondable with PDMS microfluidic 
chip. The initial cell plating condition is equal with conventional 
PDMS/Glass chip. The BSP film was spontaneously detached from the 
PDMS chip caused by hydrolysis cleavage of the interface. The Western 




 The proposed open-access microfluidic device (OAMD) serves as a non-
destructively externally accessible microfluidic coculture platform as 
shown in Figure 3-1. In this thesis, a conventional PDMS microfluidic 
three-dimensional cell culture chip was plasma bonded to a BSP instead 
of glass to provide both closed system culture capabilities as well as 
nondestructive tissue accessibility. [59] The various BSP formulations 
were engineered out of biocompatible UV curable materials capable of 
plasma bonding and separation from PDMS while maintaining tissue 
integrity for the open-accessibility. BSP formulations were developed 
with considerations for plasma bondable hydroxyl groups on the surface. 
Solid BSP surfaces tend to have a high level of flatness, and short 
crosslinking time, a high degree of bonding strength and a low degree of 
chemical reactivity to organic solvents. [60] Formulations also require the 
capacity for UV nanoimprinting lithography (UV-NIL) patterning. In all, 
the proposed BSP substrate is plasma bonded to PDMS while maintaining 
both optical transparency and the ability to allow for the nondestructive 
retrieval of cultured tissues. During the cell culture process, the BSP 
substrate detaches from PDMS gradually through the absorption of 
culture medium without tissue damage, and separates from the culture 
tissue without leaving residues.  
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 Schwann cells form an electrically insulating multilayer sheath of myelin 
around the axon of motor neurons. This myelin sheath protects neuronal 
axons, provides nutritional support, and facilitates the conduction of 
action potential propagation throughout the nervous system. Myelination 
defects such as delayed myelination, demyelination, or hypomyelination 
are known cause of serve nervous system disorders. [61, 62, 63, 64] Due 
to the clinical importance of myelin in nervous system disease models, 
myelination is a significant area of research. Current in vitro models of 
myelination utilize TEM analysis to observe myelination in petri dish 
culture tissue. [65, 66, 67, 68, 69, 70, 71] Compared to the conventional 
petri dish culture in vitro platforms, microfluidic cell culture devices have 
superior tissue level reconstitution control and lower culture media 
consumption, and are generally superior to conventional petri dish culture 
methods for 3D cell culturing applications. Furthermore, the OAMD 
improves on previous microfluidic platforms by adding the possibility if 
utilizing TEM imaging to confirm pre-myelination and myelination, a feat 
which was previously highly difficult in PDMS/glass closed microfluidic 
devices. For this publication, the OAMD platform was utilized to induce 
myelination on a coculture of motor neurons and Schwann cells, and 
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verified myelination through TEM imaging of tissues nondestructively 




















3-2. Materials and Method 
3-2-1. Biocompatible and Self-detachable Photopolymer 
As showed in figure 3-2, the main binder was composed three kinds of 
materials; PEG-DA, TMPTA and HDDA with a photoinitiator. The PEG-
DA surfaces were fabricated using the UV replica molding method in 
which PEG-DA UV curable solution was mixed with 97 wt% (by mass) 
of Polyethylene glycol diacrylate (PEG-DA, Mn 250, Sigma-Aldrich, 
viscosity 15 ~ 35 cP) pre-polymer with 3 wt% of 1-hydroxy-cyclohexyl-
phenyl-ketone (Irgarcure 184, BASF) as photo-initiator. The BSP-1 is 
formulated as 29 wt% of Hexan-1,6-dioldiarcrylate (HDDA, M200, 
Miwon Specialty Chemical, South Korea) with 39 wt% of 
Trimethylopropane triacrylate (TMPTA, M300, Miwon Specialty 
Chemical, South Korea) prepolymer with 29 wt% of PEG-DA with 3 wt% 
of 1-hydroxy-cyclohexyl-phenyl-ketone (Irgarcure 184, BASF). The 
BSP-2 was mixed with 38 wt% of HDDA, 59 wt% of TMPTA and 3 wt% 
of PI (Igarcure 184) without the PEG-DA component. A flexible and clear 
polyester film was pretreated on both sides for enhanced adhesion to the 
UV curing resin (Thickness: 100 µm, skyrol V7200, SKC, Korea), was 
then placed on the UV resin and roll-pressed against the liquid ten times 
at a pressure of 2 ~ 3 bars. The PEG-DA layer thickness was measured to 
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be 30 ~ 40 µm after pressure rolling. [60] Next, the BSP layer was cured 
under UV light for 60 seconds (UV wavelength: 250–400 nm, dose: 100 
mJ/cm2). After separating the PE backing panel from the wafer, a flat 
PEG-DA sheet was obtained on the PE Film. The BSP replica flat film 








Figure 3-2. a) The biocompatible and Self-Detachable Photopolymer 
(BSP) was composed as UV-curable pre-polymer. The main binder was 








3-2-2. Open-Access Microfluidic Device 
 The negative micro structured master was fabricated using a 
conventional lithography process with SU-8 photoresist (SU-8 100, 
MicroChem. the USA) for the positive micro structure patterned 
microfluidic chip. The mold was replicated from the negative patterned 
SU-8 master using PDMS (Sylgard 184, Dow Corning, USA) as 10:1 ratio 
PDMS and curing agent.18 The comparatively large inlet/outlet ports were 
punched via medical grade skin biopsy punch (diameter 1mm, 6 mm, Picu 
Punch) for hydrogel, cell and media injection channels. The microfluidic 
chip for BSP was created using air plasma at the fixed condition of 45 
sccm, 50 mTorr, 50 W, and 1 min (CUTE MPR, Femto Science, Korea), 
leaving behind a microfluidic channel with a flat surface for the 
microscale membrane. Post treatment was applied at 200 , 30 min for 
confinement bonding properties as bonding force, bonding time. 
 
3-2-3. Contact Angle Measurements 
 A drop shape analyzer (DSA-100, KRUSS) equipped with a camera was 
used to measure the contact angles of drops of 3 µL in volume.  
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3-2-4. Scanning Electron Microscope (SEM) 
 Images were taken using high-resolution SEM (Hitachi S4800). Samples 
were coated with a 2 nm Pt layer prior to analysis to prevent charging. 
 
3-2-5. Swelling Ratio 
 The specimen has a diameter of 2 cm × 2 cm and a thickness of 100 
micrometers. The specimen is dried in an oven at 50  for 24 h, cooled 
in a desiccator and immediately weighed. The test specimens are 
immersed in water at a cell culture temperature of 37  for 24 h, then 
taken out to remove water from the specimen surface and weighed 
immediately. The difference in weight obtained here is expressed in %. 
 
3-2-6. Nano Indentation 
The nano indentation test was taken using Nano Indenter XP (MTS, 
USA). The samples were fabricated in a thin film on a silicon wafer coated 
with a primer. The thickness of each sample was 20 ± 2 µm. The nano 
indenter used a berkovich diamond tip and the roundness was 40 nm. The 
load was pressed with a depth of 500 nm and a force of 45 mN. 
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3-2-7. Live/Dead Assay 
 The Live/Dead viability test was taken using the kit of calcein AM and 
ethidium homodimer-1 for mammalian cell. The media for primary 
cortical neuron was used neuro basal medium (NBM) with B27, 
GlutaMax and Peniciline-Streptomycin (Gibco, Lifetechnology). The 
media for human lung fibroblast (LF, Lonza) and human umbilical vein 
endothelial cell (HUVEC, Lonza) were used FGM-2 (Lonza) and EGM-2 
(Lonza). 
  
3-2-8 Energy-dispersive X-ray spectroscopy (EDXS)  
 The surface element of BSP film was analyzed at the surface of the self-
detached hydrolytic cleavage. The open access microfluidic device was 
dipping into the deionized water in 2 days. The BSP-2 was dried at the 70 
degree, 30 min. The EDXS was used X-maxN (Oxford Instrument). 
 
3-2-9 Universal Testing Machine (UTM)  
 The mechanical modulus was analyzed using universal testing machine 
(UTM, Instron 3343). The BSP sample was fabricated 20 mm of width, 
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0.2 mm of thickness and 30 mm of height. The sample was dipping in the 
deionized water during 6 days. 
 
3-2-10. MN-SC Coculture on a Microfluidic Chip. 
 All animal experiments have been conducted in accordance with 
protocols approved by the Institutional Animal Care and Use Committee 
(IACUC) at the Korea Institute of Science and Technology. As previously 
described, motor neuron (MNs) and Schwann cells (SCs) were cultured.24 
Briefly, MNs isolated from the spinal cord of CD-1 mice (embryonic day 
13) were purified by using immunopanning dish pre-incubated with 
p75NTR antibody (Abcam) in 10 mM tris – cl solution (T& I) at 4  
overnight. To culture SCs, isolated SCs from the sciatic nerves of CD-1 
mice (postnatal 4) were trypsinized with a mixture of 2.5 % trypsin (Gibco) 
and 1mg/ml collagenase A (Roche) for 30 min. The mixture of collagen-
Matrigel were loaded in the gel channels before seeding the MN and SCs 
on each chamber. Co culture medium consisted of neurobasal with 2 % 
horse serum (Thermo), 0.5 mM L-glutamine (Invitrogen), 1 % 
penicillin/streptomycin (P/S, Sigma), 1 mM ß-mercaptoethanol, 0.5 µM 
forskolin (Sigma), 0.5~2 mg/ml bovine pituitary extract, and 10 ng/ml 
 41 
brain-derived neurotrophic factor (BDNF, Prospec) and changed twice a 





































3-2-11. ICC: Immunocytochemistry 
 At DIV 20, sample was fixed with 4 % Paraformaldehyde (PFA) for 20 
min and then treated with 0.1% triton x-100 for 20 min, followed by 
incubation with 4% BSA at 4  C overnight. The sample was labeled with 
primary antibodies, which included anti-myelin basic protein (MBP, 
Abcam, 1:500), anti- tubulin beta III (TuJ1, Abcam, 1:500), and DAPI 
(Life technologies). Secondary antibodies used were goat anti-rat IgG 
H&L (1:500) and goat anti-chickenIgY H&L (1:1000). 
 
3-2-12. Western Blotting 
 The cells at DIV 10 and 20 were lysed in RIPA buffer (Biosesang) with 
protease inhibitor (Sigma). The protein concentration of cell lysates was 
measured by Bradford assay. The protein (4 µg) from each sample was 
loaded in SDS loading buffer (Bio-rad) and then transferred to a PVDF 
membrane (Bio-rad). The membranes were incubated with anti-MBP 
(Abcam, 1:1000) or anti-beta-actin (Cell signaling, 1:1000) antibodies at 
4  overnight. After three 15 min washes with TBST (190 mM NaCl, 25 
mM Tris, and 0.05% Tween 20, pH 7.5), membranes were incubated with 
anti-rat IgG-HRP (Bio-rad, 1:500) or anti- rabbit IgG- HRP (Cell 
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signaling, 1:1000) secondary antibodies for 1h at RT, and visualized using 
the Clarity Western ECL substrate (Bio-rad). 
 
3-2-13. Cryo-Transmission Electron Microscope 
 Cryo-transmission electron microscope was performed at advanced 
analysis center at Korea Institute of Science and Technology (KIST, 
Korea). Briefly, cocultured samples at day in vitro (DIV) 10 and 20 were 
fixed with 4 % glutaraldehyde (Sigma) in PBS solution at 4  overnight. 
Following treatment with 1 % osmium tetroxide for 30 min at room 
temperature, samples were dehydrated in an increasingly concentrated 
series of ethanol solutions (70 %, 80 %, 85 %, 90 %, 95 %, 100 %), and 
embedded in epoxy resin. Sections were taken between 70 ~ 80 nm using 
ultramicrotome (Leica, Ultra Cut C), picked up on Cu grids, and stained 
in uranyl acetate in acetone followed by staining in lead citrate. Images 






3-3. Results and Discussion 
3-3-1. Biocompatible and Self-detachable Photopolymer 
 The utilization of photopolymer is well adopted within the industry due 
to relatively fast curing speeds, nanopatterning capabilities, and high 
productivity by roll to roll process. In the Figure. 1b, the proposed 
platform investigated several formulations of various photo curable 
biocompatible materials for suitability. Polyethylene glycol diacrylate 
(PEG-DA) was used as a baseline biocompatible UV curable substrate. 
Trimethylolpropane triacrylate (TMPTA) and 1,6-Hexanediol diacrylate 
(HDDA) were investigated as UV curable substrates with potentially 
improved biocompatibility over PEG-DA. TMPTA is understood to 
possess a higher biocompatibility due to the increased crosslinking 
density afforded by its three acryl groups, compared to the two acryl 
groups and lower density in PEG-DA. HDDA, possess two acryl groups 
and used the competitive materials of PEG-DA. These UV curable 
materials (HDDA, TMPTA and Igarcure 184) were conventional pre-
polymer as a raw materials of optical sheet component, such as a prism 
sheet, diffusion sheet of LCD light guide panel. These materials have a 
high cost competitive price as a point of mass production. The UV curable 
BSP was applied to a Si wafer for fabrication of the flat substrate, and on 
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a nano/micro patterned silicon master for the fabrication of the positive 
nano/micro patterned substrate. Thus far, PEG-DA has been the 
biocompatible UV curable material of choice, however, this publication 
has resulted in new formulations of UV curable biocompatible materials 
which may be more suitable. 
 Separation profiles were verified experimentally as shown in Figure 3-1. 
The OAMD was constructed in conventional closed microfluidic chip, by 
plasma bonding the patterned PDMS chip to the BSP substrate. Once 
assembled, the device was loaded conventionally with acellular and cell 
suspension hydrogels for three-dimensional patterning surface 
hydrophilicity and hydrophobicity are important factors in both plasma 
bonding and hydrogel patterning. This shows that the degree of 
modification of the hydroxyl groups of the surface can be confirmed by 
monitoring the change of contact angles in Figure 3-4. Contact angles 
were measured immediately after BSP fabrication, immediately after 
plasma surface treatment, and 24 h post treatment. It is important to note 
that the 24 h post treatment contact angle of the PEG-DA and BSP 
surfaces were found to be the same as that of 24 h post treatment glass. 
Initial contact angles were measured at around 50 degree pre-plasma 
treatment, and 20 to 35 degree immediately post treatment. 24 h post 
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treatment, contact angle recovery was measured to be 30 to 45 degrees. 
These trends show that PEG-DA and BSP have potential as glass 
substitutes in terms of hydrogel patterning related hydrophobicity. As 
shown in Figure 3-5, PDMS to BSP bonding strength was extensively 
assessed to determine whether or not the bond could survive the forces of 
cell patterning injection stresses. PDMS/BSP bonding strengths were 
found to be equivalent to that of PDMS/Glass bonds, with material failure 
generally occurring in the PDMS, and confirming the suitability of 
PDMS/BSP for cell patterning. As shown in Figure. 3-5, 1 cm diameter 
of PDMS/BSP area was capable of supporting a weight of 1.8 kg. The 
flexible linear microfluidic chip show in Figure 2b-i, as well as the three-
dimensional microvessel on a chip in Figure 2b-ii demonstrates the ability 
to conduct substrate mechanical manipulation and deformation within a 
conventionally closed microfluidic platform. BSP can also be easily 
duplicated and patterned on a flat silicon surface by UV nanoimprinting 
lithography. As shown in Figure 3-6, plasma bonded PDMS with BSP-2 
was confirmed FE-SEM that the interface was conformal contacted and 
bonded. The FE-SEM image is a cross-section of a post-designed such as 




Figure. 3-4. The initial contact angle (Before) and air plasma treated surface 
(After) was analyzed using contact angle analysis. The waster has a similar 
wetting properties on the BSP surfaces. The plasma treated hydrophilic surface 












Figure. 3-5. a) The PDMS bonding strength which bonded with BSP was 
analyzed as a shear bonding strength test. The bonding area was a 1cm 
diameter slab of PDMS. The point of failure was generally in the PDMS 
slab, evident through the thin layer of PDMS remaining on intact BSP 
film. Shear bonding strength between BSP and PDMS were determined 
to be similar to that of PDMS and glass. The 1 cm of PDMS/BSP bonding 






Figure. 3-6. a-i) The single channel embedded OAMD was fabricated and 
rolled around a glass bar and the rhodamine b solution was injected in the 
chip which has high flexibility. The scale bar indicates 1 cm. a-ii) The 
multi-channel embedded organ on a chip was bonded with BSP substrate. 
As compress by mechanical movement at the edge of the microfluidic chip, 
the tissue can be stimuli as physical bending force. The scale bar indicates 
5 mm. a-iii) The upper image was a schematic illustration of the PDMS 
microfluidic chip bonded with BSP. The FE-SEM image was cross-
section image of the micro post embedded chip for reconstitution of 




3-3-2. Biocompatibility and Mechanical Properties 
 Biocompatibility for each composition was verified by viability testing 
with primary rat cortical neurons in two-dimensional cultures in Figure. 
3-7. In the live/dead assays for the UV curable substrates, the following 
viability rates were found to be the following: 28 % for PEG-DA, 51 % 
for BSP-1 and 76 % for BSP-2. The observed data suggests a correlation 
between tri-acrylate functional groups and higher biocompatibility. 
Generally, the tri-acrylate group molecules have higher cross-linking 
densities when compared to di-acrylate group materials post UV curing. 
[73, 74] Interestingly, PEG-DA containing BSP-1, and PEG-DA free 
BSP-2 showed little difference in viability rates, while both formulations 
showed vast improvement over PEG-DA alone. The high degree of 
biocompatibility in the investigated HDDA and TMPTA formulations 
indicates potential as a potentially superior alternative to PEG-DA as a 
UV curable bioengineering materials. The substrate mechanical properties 
were importance function on research area of the cell differentiation, 





Figure 3-7. a) The Live/Dead assay of the LF, HUVEC and primary rat 
cortical neuron were applied on each PEG-DA and BSP-1, 2, for the 
biocompatibility. The BSP-2 have a high viability about the primary rat 
cortical neuron. b) The biocompatibility of BSP-2 was much higher 
than BSP-1 and PEG-DA substrate. The scale bar indicates 100 µm.  
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Figure 3-8. a) The BSP-1, 2 and PEG-DA have diverse mechanical 
properties for the two-dimensional cell culture platform. b) The BSP, 
UV-curable materials, was capable duplicate of nanopattern for 
topographical research. The FE-SEM image show the replicated 
nanopattern with 800 nm width and 800 nm space line patterns. The 
scale bar indicates 1 µm. The primary rat cortical neuron was cultured 
on the BSP-2 a nanopatterned surface which was coated by poly-D-
lysine. The axon was well aligned with the line pattern direction. The 




 As shown in Figure. 3-8, the BSP materials were measured for hardness 
and elastic modulus values by nanoindentation. PEG-DA (Mn 250) has 
relatively hard physical properties due to its relatively short molecular 
length. [78] BSP materials containing TMPTA have higher hardness and 
elastic modulus values than those without. Higher hardness is attributed 
to the high cross-linking density of the triacrylate group, while the overall 
small molecule size contributes to high elastic modulus values These 
values have a similar level with bone [79] surface elastic modulus values 
in vivo. Although the diverse formulations of BSP exhibited a wide range 
of elastic moduli, it was found that high elastic modulus has high 
biocompatibility which was favorable characteristic for the proposed 
platform. UV nanoimprinting lithography (UV-NIL) was used to 
nanopattern BSP surfaces, as confirmed in Figure. 3-9. Biocompatible 
nano patterned molds which duplicated by UV-NIL can be used for cell 
adhesion, directional guidance, outgrowth and accelerated outgrowth. [80] 
The patterned surface with a line width of 800 nm, and a space ratio of 
1:1 and 1:3, 1:5 was coated in poly-D-lysine in Figure 3-10. The 
nanopatterned device was then used for a DIV 14 culture of primary rat 
cortical neurons for axonal outgrowth observation in Figure 3-10. Cellular 
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alignment was found to be consistent with the orientation of the 1: 5 


















Figure 3-9. FE-SEM images of nano patterned diverse materials. All of the 
conditions were duplicated from the negative phase patterned silicon wafer 








Figure 3-10. UV-NIL was carried out with BSP-2 material. Line width of 400 
nm and 800 nm, and a space ratio of 1 : 1, 1 : 3, 1 : 5. The surface was coated 
with PDL and cells were cultured. On top of this, primary cortical neurons were 
cultured for 2 weeks to observe how the axons outgrowth. We could confirm the 
outgrowth consistent with the orientation of the nanopattern in the 1: 5 line / 
space pattern. Such low viability cells need to be studied with higher 
biocompatibility polymers. The primary cortical neuron was plated 0.1 mil/ml in 







3-3-3. Self-detachable for Open-access Organ on a Chip 
 As shown in Figure. 3-11a, the schematic illustration of the OAMD was 
presented. The substrate was optically transparent film, and self-detached 
from the PDMS microfluidic device. The interface, which was plasma 
bonded PDMS with BSP-2, was spontaneously separated by hydrolysis 
cleavage. In Figure 3-4 which was shown the bonding strength analysis, 
before the water absorption, the mechanical failure was shown the PDMS 
cohesive area. The other way, during the tissue culture on the OAMD, the 
cell culture media was spontaneous infiltrate the plasma bonded interface. 
After the hydrolysis cleavage of the bonded interfaces, the BSP film was 
not shown any residue material such as the Matrigel and collagen which 
was injected into OAMD. This is the strong point for the without structure 
damages sampling of the for the TEM analysis. The PEG-DA and BSP 
have the self-detachable characteristic which was used as substrate 
materials on a microfluidic device. The self-detachable properties, as 
mentioned before, was induced by the water absorption characteristic. In 
Figure 3-11b, the glass did not show the water absorption property, but 
the PEG-DA and BSP materials showed the water absorption properties. 
The 5% of PEG-DA, 3 % of BSP-1 and 2.5 % of BSP-2 were shown using 
the DI water swelling ratio test. The cell culture on the OAMD, the 
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substrate was self-detached after 2 days when using the PEG-DA. And the 
BSP materials were shows that 1 day of BSP-1 and 12 h of BSP-2 in 
Figure. 3-11c. The separation area was spontaneously increased and 
finally, the whole BSP film was totally separated after 2 days. The 
Different combinations of substrate materials can be employed to 
modulate the separation rates between the base and the main device. The 
self-detachable film was generated by hydrolytic cleavage by hydrolysis 
reaction at the carboxylate ester group which was the native chemical 
structure of the BSP resin molecule. Generally, PDMS and organic 
substrate bonding interface are vulnerable to the hydrolysis reaction. 
Especially, the carboxylate ester group was vulnerable to the hydrolytic 
cleavage. In Figure 3-12, using the PEG-DA, HDDA and TMPTA as the 
raw materials of substrate which obtained the carboxylate ester group 
natively. The PEGDA and HDDA had a two-carboxylate ester group and 
the TMPTA has a three-carboxylate ester group. These materials mean 
chemically unstable structure at the hydrolytic reaction. In Figure 3-13, 
the self-detached BSP surface, which was bonded with PDMS area, was 
analyzed using energy-dispersive X-ray spectroscopy (EDXS) for the 
confirm the self-detachable photopolymer system. 
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If the hydrolytic cleavage was generated in the PDMS area, the BSP 
surface was obtained the Si atoms. But the BSP surface was not detected 
the Si atoms. This means the hydrolytic cleavage was generated in the 
BSP area. Also, the cleavage of the open access microfluidic device 
(OAMD) was generated only wet condition. In Figure 3-14, the 
mechanical modulus of the wet conditioned BSP was decreased versus 
dry conditioned BSP. The decrease of the mechanical property was the 
proof of the hydrolysis reaction was generated in the BSP film. PEGDA, 














Figure. 3-11. a) The schematic illustration of spontaneous detachment for 
BSP integrated open-access microfluidic chip. The BSP was smoothly 
detached without any tissue residue on the surface. b) The swelling ratio 
was analyzed for the spontaneous detachment of BSP. The PEG-DA and 
BSP have swelling property compared with a glass substrate. c) The PEG-
DA was bonded 48 h, and BSP-1, 2 were bonded 24 h, 6h in the aqueous 
medium solution which was bonded 1 cm diameter PDMS slab. The 







Figure. 3-12. The illustration of the open access microfluidic device. The 
self-detachable film was generated by hydrolytic cleavage by hydrolysis 
reaction at the carboxylate ester group which was the native chemical 









Figure. 3-13. The open access microfluidic device was separated at the 
self-detached BSP film. The Si atom was not detected on the BSP film 











Figure. 3-14. The cleavage of the open access microfluidic device 
(OAMD) was generated only wet condition. The mechanical modulus was 










We examined the formation of the myelin sheath in the PNS model, by 
analyzing myelin basic protein (MBP) expression. At DIV 20, MBP 
expression was checked confocal microscopy in Figure 3-15. The 
myelinating stage at DIV 20, MBP expression appeared to be highly 
localized along the motor neuron axon which was demonstrated the 
myelinating stages in 2-D coculture. In the two-dimensional coculture, 
myelination initiated by migration of SCs toward axons was classified into 
the two distinct stages on the basis of the MBP expression pattern in the 
myelinating SCs process. The pre-myelinating stage was diffused of SCs 
toward around the MN axons, and the myelinating stage was the well-
defined along the axons by progress to a tightly localized. Also, the myelin 
basic protein (MBP) and beta-actin expression were confirmed by western 
blot by the BSP-2 used OAMD in Figure 3-15. As shown in Figure 3-16, 
pre-myelination was confirmed at DIV 10 and complete myelination at 
DIV 20 for the thickness of myelin sheath using the transmission electron 
microscope (TEM). TEM imaging was made possible by the 
nondestructive open-access of the cultured tissues via the BSP. As shown 
in Figure 3-16, the myelin structure was analyzed as high precision which 
was cultured on the microfluidic chip of PNS. As demonstrated, the 
OAMD is capable of highly specialized and controlled microfluidic cell 
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culture, as well as the ability to allow for nondestructive tissue collection 
for detailed imaging. OAMD techniques can be further applied to many 
other microfluidic cell culture schemes to allow detailed imaging and 
sampling techniques that have been previously impossible due to the 


















 Figure 3-15. a) The illustration of peripheral nervous system (PNS) 
myelin structure composed by MN and SCs. The SCs was myelinated on 
the MN axon. The three-dimensional myelin structured tissue was open to 
the air without any coverage materials. The inset image was showed the 
whole chip of open-access microfluidic chip after tissue culture. The scale 
bar indicates 2 mm. The microscope image was showed the motor neuron 
(left) and Schwann cell (right). The scale bar indicates 500 µm. b) The 
immunocytochemistry was applied for the MBP and TuJ1 expression 
about the myelination. c) The myelin basic protein and beta-actin were 




Figure 3-16. a) TEM imaging verified pre-myelinating SCs by DIV 10, 
and complete myelinating SCs by DIV 20. The left image scale bar 
indicates 100 nm and scale bar of the magnified image indicates 20 nm. 
This accessibility of BSP integrated open-access microfluidic chip was 











 This publication proposed the use of HDDA and TMPTA as 
biocompatible and self-detachable photopolymers (BSP) as a substrate for 
the proposed open-access microfluidic device (OAMD) platform. The 
ability of the OAMD platform to allow for the non-destructive sampling 
of cultivated tissues allows for previously impossible. BSP as the UV 
curable materials can be utilized as transparent, flexible and nano 
patternable substrates for topographical cell behavior research through 
UV nanoimprinting lithography (UV-NIL). The BSP can be plasma 
bonded to PDMS and possesses strong bonding strengths similar to those 
of glass. Biocompatibility of the BSP was verified by the live/dead assay 
of primary rat cortical neurons in two-dimensional culture, and three-
dimensional reconstituted PNS tissue. BSP shows a higher water 
absorption rate compared to that of conventional glass. Consequently, the 
self-detachment of BSP from PDMS occurs spontaneously over the 
course of the cell culture. Myelination was confirmed via western blot and 
TEM through non-destructive OAMD sampling. The direct and 
nondestructive accessibility of OAMD culture systems through the use of 
BSP shows great promise in any research applications which require 
direct tissue sampling and high accessibility for structural analysis. 
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Chapter 4 
Vascularized tissue transplantation from open-
access microfluidic device for regenerative 
therapy of PAD 
 
4-1. Introduction 
 As show in Figure 4-1, for develop safe and effective procedures for 
vascularized tissue injection, we focused on regenerative medicine 
technology using “Open microfluidic device”. Vascularized Tissue (VT) 
formation is a well-known process associated with microvessel culture 
processes, and using microfluidic device with several advantageous 
features for organ on a chip. For example, the VT has a 3-D structure that 
may provide a rich extracellular matrix that is more relevant to the in vivo 
environment. Furthermore, VT can be defined to form certain 
microstructure. We herein report a novel open microfluidic device that 
yields functional and vascularized tissue that can be successfully 
transplanted into the Balb C Nu nude mouse. 
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Figure 4-1. Schematic of fabrication of VT transplantation for PAD 
model. Double side through-hole membrane was integrated 3D printed 
microfluidic device. The transplantable microfluidic device was culture 
as a 6-well plate culture system. During the culture of the vascularized 
tissue, plasma bonded PEG-DA through-hole membrane was 
spontaneously detached by water absorption of the culture media. The VT 
was transplanted to the hindlimb ischemia model as a regenerative 
medicine.   
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4-2. Materials and Method 
4-2-1. 3D Printed Microfluidic Device 
 The 3D printed microfluidic device was used the stereolithography 
apparatus (SLA) and digital light process (DLP) system. The Projet® 1200 
Micro-SLA printer was used as the commercially available for the easily 
assembled 3D printed microfluidic device. The photoresin was used the 
Visijet® FTX Green (3D SYSTEMS, USA) which used for micro-fine 
detail casting patterns and plastic parts with dark green color. The Projet® 
1200 Micro-SLA has a 56 µm (585 dpi) of XY resolution and 30 µm of Z 
layer resolution. And, the LITHO® (Illuminaid, Korea) used for the 
custom 3D printing of PEGDA photoresin which has a biocompatibility 
and transparency. LITHO has 82 µm of XY resolution and from 25 µm to 
200 µm of Z layer resolution. Figure 4-2 was show the schematic 
illustration of the 3D printed microfluidic device and the integrated on the 





Figure 4-2.  a) The side and top view images were shows as use of the 
insert part which made by the 3D printing technology. Cross-sectional 
image of 3D Microfluidic device. The top and bottom materials were 
composed as PEG-DA photoresin which has a 200 µm diameter through-
hole membrane. b) The green colored insert part was printed using 
commercial UV curable resin using commercial 3D printer. The clear 
insert part was printed customized 3D printer with customized PEG-DA 
resin. 
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4-2-2. Photoresin Preparation 
 The PEG-DA resin were fabricated using the UV replica molding 
method in which PEG-DA UV curable solution was mixed with 97 wt% 
(by mass) of Polyethylene glycol diacrylate (PEG-DA, Mn 250, Sigma-
Aldrich, viscosity 15 ~ 35 cP) pre-polymer with 3 wt% of 1-hydroxy-
cyclohexyl-phenyl-ketone (Irgarcure 184, BASF) as photo-initiator. All 
these steps were done in the dark to avoid spontaneous reaction with 
ambient light.  
 
4-2-3. Surface Treatment 
 Parylene C deposition on 3D printed microfluidic device was performed 
with a commercially available parylene coater (LAVIDA, FEMTO 
SCIENCE). Temperatures used for vaporization, pyrolysis and deposition 
of parylenes were 680 ◦C and room temperature. Vaporized parylene-
monomers attached the 3D printed microfluidic device. After the parylene 
coating process, the PDMS thin layer was coated on the microfluidic cell 
loaded area for the plasma bonding with PEG-DA through-hole 
membrane. The microfluidic channel was dip coated using mixture of 
PDMS prepolymer. The thickness of the coated PDMS layer was 10 ~ 20 
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µm. This interface PDMS PEG-DA through-hole membrane which was 
supplied the open-access microphysiological system. 
 
4-2-4. Through-hole Membrane Integration 
 The membrane was fabricated in three simple steps. The first step 
combines plasma bonding of the top part of a PDMS microfluidic chip 
with a flat substrate. The microfluidic chip for the through-hole membrane 
was created using air plasma under fixed conditions of 45 sccm, 50 mTorr, 
50 W, and 1 min (CUTE MPR, Femto Science, Korea), leaving behind a 
microfluidic channel with a flat surface for the microscale membrane. The 
second step was curing of membrane materials, the chip was exposed to 
UV light for 180 s (UV wavelength = 250–400 nm, dose = 100 mJ cm−2). 
The third step is separating the membrane by mechanical failure, using a 
scalpel and mechanical force. The PDMS microfluidic chip edge was 
severed using a scalpel and the micro/nanopillar substrate was separated 
by cohesive mechanical failure on the bottom surface after curing. The 
experimental through-hole membrane was fabricated by applying the pre-
polymer membrane material through a PDMS microfluidic chip patterned 
with distribution channels into a mold. For microscale membrane 
production, the PDMS microfluidic pre-polymer distribution chip is also 
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patterned with positive micropillars (diameter 200 µm) and plasma 
bonded to a flat surface backer, like glass. Post injection, the assemblies 
are cured and then the membranes are mechanically extracted for use. The 
negative micropillar patterned master was fabricated using a conventional 
lithography process with SU-8 photoresist (SU-8100, MicroChem, USA) 
for the positive micropillar patterned microfluidic chip. The mold was 
replicated from the negative patterned SU-8 master using PDMS (Sylgard 
184, Dow Corning, USA). The comparatively large inlet/outlet ports were 
punched via 1 mm medical grade skin biopsy punch (diameter 1 mm, Picu 
Punch) for membrane material injection channels. 
 
4-2-5. Cell Culture and Vasculogenesis Cell Seeding  
 Human umbilical vein endothelial cells (HUVEC, Lonza) were cultured 
in Endothelial Growth Medium (EGM-2, Lonza) and passages 5 to 7 used 
for experiments. Normal human lung fibroblasts (LF, Lonza) were 
cultured up to passage 10 in Fibroblast Growth Medium (FGM-2, Lonza). 
Cell cultures were grown to 80% confluence prior to passage or use in 
experiments. All cells were maintained in a humidified incubator at 37 uC 
and 5 % CO2. The fibrinogen solution was prepared by dissolving 2.5 
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mg/ml bovine fibrinogen (Sigma) in DPBS (Gibco) and supplementing 
aprotinin (0.15 U/ml, Sigma) and collagen type I (0.2 mg /ml, BD 
bioscience) to the solution. Collagen type I was added to the pure fibrin 
matrix to enhance lumen formation of developing tubular structures. After 
disassociation from culture dishes using 0.25% Trypsin-EDTA (Hyclone), 
HUVECs and LFs were suspended in the fibrinogen solution, at a 
concentration of 5 × 106 cells/ml for HUVECs and 5 × 106 cells /ml for 
LFs. The cell solutions were mixed with thrombin (0.5 U/ml, Sigma) and 
then immediately injected into a microfluidic channel and substrate of 6 
well plate. The 6-well of the cell culture medium were loaded with EGM-
2 medium. Following loading the 6-well plate as showed in Figure 4-3, 
the microfluidic platforms were incubated at 37  and 5% CO2. The cell 
culture medium was removed and refilled with fresh EGM-2 culture 







Figure 4-3. Schematic illustration of the tissue culture platform using 6-
well plate system. The bottom layer was coated by lung fibroblast for 







4-2-6. Immunostaining and Imaging  
 Mouse monoclonal antibodies specific for CD31 (Alexa Fluor1647, 
clone WM59) was purchased from BioLegend. Mouse monoclonal 
antibody specific for Hoechst 33342 was from Molecular Probes. After 
washing cultures once with phosphate-buffered saline (PBS, Hyclone), 
cells were fixed in 4% (w/v) paraformaldehyde in PBS for 30 min. After 
blocking using 3% bovine serum albumin (BSA, Sigma) in PBS for 1 h, 
samples were incubated overnight at 4 uC either with primary antibodies 
directly conjugated with fluorescent marker (CD31; 1 : 200). For staining 
nuclei, Hoechst 33342 (1 : 1000) were added to the chip for 1 h of 
incubation at room temperature. The samples were washed three times 
and stored in PBS before imaging. For cross-section and whole-construct 
imaging of 3D blood vessels, stained samples were examined using a 
FluoView FV1000 confocal laser scanning unit with the IX81 inverted 
microscope (Olympus) and images were captured with a confocal PMT 
detector. Lenses in use were ×10, ×20 and ×40 (Olympus). Confocal 





4-2-7. Hindlimb Ischemia Model and in vivo Vascularized  
Hydrogel Implantation.  
 All animal experiments were performed using protocols approved by the 
Seoul National University Institutional Animal Care and Use Committees. 
BALB/C-nu mice (female, age 6 weeks, weighing 20~25 g) were 
purchased from Orient Bio (Orient Bio Inc, Seongnam, Korea). All mice 
were anesthetized with an intraperitoneal injection of Zoletile 50 
(Tiletamine + Zolazepam, 0.006 ml/10g) and Rompun (Xylazine, 0.004 
ml/10g) and the inguinal skin was incised along with the femoral artery 
visible through the skin. The femoral artery was excised from its proximal 
origin as a branch of the external iliac artery to the distal point where it 
bifurcates into the saphenous and popliteal arteries. After femoral artery 
excision, the mice was treated with PBS (400 µl, Control group), hydrogel 
(Gel group), HUVEC (5 million cells re-suspended with 400 µl of PBS, 
Cell group), HUVECs mixed hydrogel (5million cells re-suspended with 
400 µl of hydrogel, Cell + Gel group) and Vacularized hydrogel disk (400 
µl of hydrogel was vascularized with 5 million HUVECs, Vascularized 
hydrogel group). Blood flow of hindlimb was measured via a laser 
Doppler perfusion imaging (LDPI) analyzer (Moor instruments, Devon, 
UK) on days 0, 7, 14, 21, and 28 after sample insertion. The degree of 
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blood perfusion was calculated on the basis of colored histogram pixels. 
Blood perfusion is expressed as the LDPI index indicating the ratio of 
ischemic versus non-ischemic limb blood flow. The scores of necrosis in 
the ischemic hindlimb were assessed on day 28 after surgery (0: salvage 
of limb, 1: toes amputation, 2: foot amputation, 3: limb amputation). 
 
4-2-8. Histological Analysis and Immunostaining 
 For histological evaluation, muscle tissues of hind limb were isolated 
and fixed with paraformaldehyde (4% PFA). The day after, tissues were 
placed in 20 w/v% sucrose in PBS for overnight at 4. Then, tissues were 
transferred into OCT compound (Tussue-Tek®) and 20 w/v% sucrose in 
PBS mixed solution (OCT compound: 20 w/v% sucrose in PBS = 1 : 1 
volume ratio). After two hours, the samples were placed in the cryo-mold 
and the cyro-mold was filled with OCT compound. Tissue embedded 
cryo-mold was solidified in isopentane solution chilled by liquid nitrogen 
and the frozen tissue block was sectioned using cryostat (thickness = 10 
µm). The tissue sections were immunostained with CD31 (endothelial cell 
marker, 550274, BD Biosciences) and α-smooth muscle actin (smooth 
muscle cell marker, ab5694, Abcam) primary antibodies. The samples 
were incubated with Alexa Fluor 488 goat anti–rat or Alexa Fluor 594 
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goat anti-rabbit secondary antibody (Life Technologies) and the nuclei 
were counterstained with 4’,6 – diamidino-2-phenylindole (DAPI).  
 
4-2-9. Self-detachable for Advanced Analysis of Organ on a 
Chip 
 As shown in Figure. 4a, c, the schematic illustration of the VT was 
presented. The substrate was optically transparent film, and self-detached 
from the PDMS microfluidic device. The interface, which was plasma 
bonded PDMS with BSP-2, was spontaneously separated by hydrolysis 
cleavage. In Figure. 2a which was shown the bonding strength analysis, 
before the water absorption, the mechanical failure was shown the PDMS 
cohesive area. The other way, during the tissue culture on the OAMD, the 
cell culture media was spontaneous infiltrate the plasma bonded interface. 
After the hydrolysis cleavage of the bonded interfaces, the BSP film was 
not shown any residue material such as the Matrigel and collagen which 
was injected into OAMD. This is the strong point for the without structure 
damages sampling of the for the TEM analysis. The PEG-DA and BSP 
have the self-detachable characteristic which was used as substrate 
materials on a microfluidic device. The self-detachable properties, as 
mentioned before, was induced by the water absorption characteristic. In 
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Figure. 4b, the glass did not show the water absorption property, but the 
PEG-DA and BSP materials showed the water absorption properties. The 
5% of PEG-DA, 3 % of BSP-1 and 2.5 % of BSP-2 were shown using the 
DI water swelling ratio test. The cell culture on the OAMD, the substrate 
was self-detached after 2 days when using the PEG-DA. And the BSP 
materials were shows that 1 day of BSP-1 and 12 h of BSP-2 in Figure. 
4c. The separation area was spontaneously increased and finally, the 
whole BSP film was totally separated after 2 days. The Different 
combinations of substrate materials can be employed to modulate the 
separation rates between the base and the main device. Figure. 5a shows 
that the PNS chip was segregated into two chambers by a collagen-
Matrigel mixture hydrogel, with motor neurons on one side and Schwann 
cells on the other. The myelin structure was reconstituted on the 
microfluidic devices in Figure. 5a. The specific experiment progress table 
was shown in Figure. S4. We examined the formation of the myelin sheath 
in the PNS model, by analyzing myelin basic protein (MBP) expression. 
At DIV 20, MBP expression was checked confocal microscopy in Figure. 
5b. The myelinating stage at DIV 20, MBP expression appeared to be 
highly localized along the motor neuron axon which was demonstrated 
the myelinating stages in 2-D coculture.24 In the two-dimensional 
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coculture, myelination initiated by migration of SCs toward axons was 
classified into the two distinct stages on the basis of the MBP expression 
pattern in the myelinating SCs process. The pre-myelinating stage was 
diffused of SCs toward around the MN axons, and the myelinating stage 
was the well-defined along the axons by progress to a tightly localized. 
Also, the myelin basic protein (MBP) and beta-actin expression were 
confirmed by western blot by the BSP-2 used OAMD in Figure. 5c. As 
shown in Figure. 5d, pre-myelination was confirmed at DIV 10 and 
complete myelination at DIV 20 for the thickness of myelin sheath using 
the transmission electron microscope (TEM). TEM imaging was made 
possible by the nondestructive open-access of the cultured tissues via the 
BSP. As shown in Figure. 5d, the myelin structure was analyzed as high 
precision which was cultured on the microfluidic chip of PNS. As 
demonstrated, the OAMD is capable of highly specialized and controlled 
microfluidic cell culture, as well as the ability to allow for nondestructive 
tissue collection for detailed imaging. OAMD techniques can be further 
applied to many other microfluidic cell culture schemes to allow detailed 
imaging and sampling techniques that have been previously impossible 
due to the closed nature of conventional microfluidic systems.  
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4-3. Results and Discussion 
4-3-1. Vascularized Tissue Process and Self-detached 
Through-hole Membrane 
 The experimental process was shown in Figure 4-4. First, the 
vascularized tissue (VT) was cultured on the 3D printed microfluidic 
device. Total culture time was day 14. The vascularized tissue was well 
obtained without any physical damages by self-detached through-hole 
membrane as mentioned before. For the VT, the through-hole membrane 
was plasma bonded until 4 days maximally and then, the membrane was 
spontaneously detached. The plasma bonding strength appeared bonding 
temperature dependent. Generally, the plasma bonding temperature was 
applied under hundred degree. But for the PEG-DA, the bonding 
temperature was not enough to the high bonding strength as shown in 
Figure 4-5a. For the PEG-DA membrane bonding, the temperature was 
applied two hundred degree and different time applied as 5 min, 30 min, 
60 min. As showed graph in Figure 4-5a, 5 days bonding strength was 
appeared by at the condition of two hundred degree and 30 min. After the 
detached through-hole, the vascularized tissue was obtained without any 
physical damages for transplantation.  
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Figure 4-4. a) The experimental progress table for the PAD regenerative 
mediciene. b) The thorough-hole membrane was spontaneously self-
detached by water absorption of the culture media. c) The VT was 
transplanted on the hindlimb ischemia after 14 days cultured.  
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Figure 4-5. a) The PEG-DA has high water absorption properties than 
glass. b) The PEG-DA show the high mechanical properties for the 
surface topographical study. c) Self-detached propertie was showed as 
spontaneously separation by hydrolysis reaction. d) The vascularized 
tissue (VT) was cultured on well plate and the right image was show the 
diameter of VT.        
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4-3-2. Vascularized Tissue Analysis 
 We analyze the growth of the HUVEC microvessel network and 
angiogenic sprouts as it occurred over several days. We used human 
umbilical vein endothelial cells (HUVECs) as vascular precursor cells, 
and human normal lung fibroblasts (LFs) as stromal cells to support 
HUVEC morphogenesis via secretion of pro-angiogenic growth factors 
and extracellular matrix proteins.[27,28] To recreate highly pro-
angiogenic ECM environments as found in wound healing and solid 
tumors,[29] we supplemented fibrin matrix with type I collagen (referred 
to simply as ‘‘fibrin matrix’’ hereafter) to form ECM constructs. A day 
after seeding, HUVECs displayed elongated morphology with appearance 
of intracellular vacuoles in Figure 4-6. Assembly of HUVECs into tubule-
like structures encompassing a nascent lumen was observed as early as 
day 2. Further development of the vasculature resulted in interconnected 
networks occupying extended areas of fibrin matrix after 3 days. 
Perfusable microvascular networks that can be directly accessed via 





Figure 4-6. Time-series micrographs of vasculogenic vessel formation in 
the fibrin matrix. Day 2, HUVECs elongate and start to connect to each 
other. Day 6, HUVECs start to form a network via a dynamic remodeling 
process, while nascent lumen structures appear. By Day 10, hollow lumina 
of HUVECs grow larger and merge to form well-interconnected tubular 
structures. By Day 14, a perfusable microvascular network is established 
as the luminal sides of the vessels are connected. The lower imager was 
show the 3D microvessel image at Day 14. The scale bar indicates 200 
µm and 300 µm 
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4-3-3. Vascularized Tissue improves recovery of blood 
perfusion and limb salvage in an ischemic hind limb. 
 To evaluate the angiogenic efficacy of vascularized hydrogel in hind 
limb ischemia model, the recovery of blood perfusion and salvage of 
ischemic tissue were assessed using several experiments in BALB/c 
mice. The amount of blood flow was measured using a laser Doppler 
perfusion imaging (LDPI) analyzer during four weeks with injections 
and implantation of 5 groups (1. Control: PBS, 2. Gel: hydrogel, 3. Cell: 
HUVECs, 4. Cell + Gel: HUVECs mixed with hydrogel 5. Vascularized 
hydrogel disk) into the ischemic hind limb. Vascularized hydrogel disk 
significantly increased blood flow and significantly reduced tissue 
necrosis in the ischemic hind limb compared with the PBS-injected 
control group in Figure 4-7. Injection of VT significantly reduced tissue 
necrosis and limb loss, whereas the control group or Gel, Cell, Gel/Cell 
injected group exhibited severe necrosis and loss of the ischemic hind 






Figure 4-7. Effects of control released VT peptides on blood perfusion, 
necrosis, and neovascularization in the ischemic hind limb. Injection of 
VT into hind limb ischemia model resulted in enhanced blood perfusion 
and neovascularization. a) Representative images of a mouse hind limb 




Figure 4-8. a) Quantitative analysis of blood flow measured by LDPI. The 
LDPI ratio was calculated as the ratio of ischemic to contralateral hind 
limb blood perfusion over the observation period. a) Statistical analysis of 




Figure 4-9. (a) Immunostaining of CD31-positive capillaries (green) or 
a-SMA-positive blood vessels (red) in ischemic limbs on day 28 after 
muscular injection. Nuclei (blue) were counterstained with DAPI and 
overlaid images are shown (scale bar = 30 µm). (b) Quantitative analysis 
of capillary density expressed by the number of CD31+ capillaries per 
high power field. (c) Quantitative analysis of a-SMA-positive blood 





 In addition, vascularized hydrogel disk significantly improved increase 
in CD31-positive capillaries and α-SMA-positive arteries/arterioles on 
day 28 after introduction of ischemia in Figure 4-9. Although the 
intramuscular injections of Gel only, Cell only, Cell + Gel (HUVECs 
mixed hydrogel) group also improved blood perfusion and angiogenesis 
compared with the control group, vascularized hydrogel disk showed the 
more significant therapeutic efficacy than these groups. These results 
suggest that the pre-vascularized scaffold effectively improves blood 














 In this thesis, we have shown that transplantable vascularized tissue on 
a chip effectively facilitated proliferation and angiogenic activities in vivo. 
Furthermore, we have engineered 3D printed biocompatible microfluidic 
device for controlled vasculogenesis and transplantatio. Our animal 
experiments demonstrated that multiple HUVEC condition injection into 
hindlimb ischemia model resulted in a pro-angiogenic response. We 
further showed that vascularized tissue led to controlled in vivo release 
and resulted in increased therapeutic efficacy of single transplantation.     
 This transplantation approach has potential to address both clinical and 
in vitro needs. The ability of a vascularized tissue to completely 
regenerate vascular tissue voids while providing interconnected as a 
synthetic alternative to grafting technology. We present a fundamental 
change in the approach to ischemic tissue regenerative therapy by using 
the open microfluidic device by formation to promote the development of 
complex three-dimensional networks on timescales previously using 
current fibrinogen hydrogel technologies. Complex combinations of 
vascularized tissue with deterministic chemical and physical properties 
may enable tissue regeneration in a range of distinct physiological niches 
(for example, neural, cardiac, skin, and so on), where VT are tailored to 
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each niche via their building-block properties. The unique combination of 
self-detached and transplantable of VT has the potential to alter the 
landscape of tissue regeneration in vivo. The results obtained in the 
present study shows the angiogenic response induced by the vascularized 
tissue in fibrinogen hydrogel, suggesting the possibility of simplifying the 





















 In this thesis, the integrated platform of through-hole membrane and self-
detached biocompatible materials on microfluidics were proposed for 
regenerative medicine of open microfluidic device.  
 In chapter 2, presents a simple approach to the fabrication of micro and 
nano scale through-hole membranes. The process itself is highly scalable, 
modular, and compatible with a very diverse range of different polymers 
to achieve desired specifications from hundreds of microns to hundreds of 
nanometers. Using this process, fabricated membranes have a high degree 
of uniformity of thickness, no residues, and no meniscus deformation at 
the through-hole sites. 
 In chapter 3, proposed the use of HDDA and TMPTA as biocompatible 
and self-detachable photopolymers as a substrate for the proposed open-
access microfluidic device platform. The ability of the OAMD platform 
to allow for the non-destructive sampling of cultivated tissues allows for 
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previously impossible. The direct and nondestructive accessibility of 
OAMD culture systems through the use of BSP shows great promise in 
any research applications which require direct tissue sampling and high 
accessibility for structural analysis. 
 In chapter 4, we have shown that vascularized tissue effectively 
facilitated proliferation and angiogenic activities of in vivo. Furthermore, 
we have engineered biocompatible through-hole membrane for controlled 
separated from microfluidic device. Our animal experiments 
demonstrated that vascularized tissue injection into hind limb ischemia 
model resulted in a pro-angiogenic response. We further showed that 
vascularized tissue resulted in increased therapeutic efficacy of single 
transplantation. 
 This result gave a novel insight to vascularized tissue transplantation of 
the regenerative medicine. Regenerative medicine by the open 
microfluidic device may be a new promising perspective to medical 
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국 문 초 록 
 말초 동맥 질환의 치료제를 개발하기 위하여 다공성 
맴브레인을 지닌 개방형 마이크로 유체 장치를 개발하여 
새로운 개방형 장기모사 칩을 활용한 혈관 배양 및 이식 
시스템의 재생 의학적 치료제로서의 접근 가능성을 연구하였다. 
말초 동맥 질환의 경우 일반적으로 동맥 또는 소동맥의 
하부에서 혈관이 막혀 혈액 공급이 원활하지 못하여 조직이 
괴사하게 되는 질환을 말하는데 말기 상태, 즉 조직이 괴사하기 
전까지 큰 자각증상이 없는 것이 특징이다. 이러한 말초 
동맥질환의 치료를 위해서는 초기에는 약물 치료를 진행하고 
말기에는 조직 이식을 통하여 혈류를 회복 시키고 궁극적으로 
말초 동맥 질환을 치료한다. 본 연구는 말초동맥질환의 말기 
상태의 병변을 치료하기 위해 관류가 이루어진 상태의 조직을 
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미세유체칩에서 먼저 배양 후 괴사 조직에 이식하여 우회 
혈관을 생성하고 궁극적으로 말초 동맥 질환을 치료하기 위한 
장기모사칩용 개방형 미세유체칩을 설계하고 증명하였다. 
이식용 미체유체칩을 개발하기 위하여 먼저 혈관 조직을 잘 
배양하고 이식 가능한 환경으로 조직의 손상 없이 미세유체 
칩을 개방하여야 한다. 따라서 선 조건이 혈관 조직의 배양을 
위하여 6 well plate 에 기반한 큰 조직의 배양과 원활한 배지 
공급을 위하여 대면적 다공성 맴브레인을 제조하는 신공정 
기술을 개발하였다. 그리고 개방형 미세 유체칩 환경을 
구사하기 위하여 기존에 잘 알려진 생체적합성 광경화 
고분자인 PEG-DA 라는 물질과 전자재료 분야에서 값싸게 많이 
사용되었으나 바이오 공학 분야에는 잘 알려지지 않은 TMPTA, 
HDDA 광경화성 물질을 도입하여 광경화에 따른 다공성 
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맴브레인 제조 공정의 장점을 극대화 하였다. 재료 자체에 내재 
되어있는 흡습성을 이용하여 혈관 형성 초기에는 닫힌 상태의 
미세유체칩의 형상으로 자가 정렬된 혈관 조직을 잘 형성하고 
배양과 동시에 맴브레인이 분리되는 시스템을 구축하였다. 이를 
이용하여 얻어진 혈관조직을 말초 동맥질환의 동물모델인 하지 
허혈 동물 모델에 이식하여 비교군과 비교하였을 때 
재혈류량이 가장 높게 증가하는 것을 확인 하였다. 본 연구에서 
개발한 개방형 마이크로 유체 장치에서 배양된 혈관조직의 
재생의학적 접근은 그동안 시도 되지 않는 새로운 시각의 
접근이라 할 수 있다. 이를 통해 말초 동맥 질환의 치료 뿐만 
아니라 다양한 질병의 치료에 있어서 조직 공학 분야에서의 
새로운 접근 방식을 제시하고자 한다. 
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